《肿瘤介入领域国际医学期刊SCI论文写作与发表巡回讲座》-广州站成功举办

2012-06-05 MedSci MedSci原创

2012年6月5日 下午《肿瘤介入领域国际医学期刊SCI论文写作与发表巡回讲座》-广州站在广州花园酒店成功召开。此次讲座由MedSci主办,中山大学附属第三医院单鸿教授担任主席。 MedSci高级学术顾问张博士就肿瘤介入领域常见问题,如何从临床设计和创新性角度挖掘高质量的临床研究,以及转化为高质量临床研究成果等角度介绍目前中国肿瘤介入领域的情况,以及如何通过规范的临床设计,发表高质量临床成果。M

2012年6月5日 下午《肿瘤介入领域国际医学期刊SCI论文写作与发表巡回讲座》-广州站在广州花园酒店成功召开。此次讲座由MedSci主办,中山大学附属第三医院单鸿教授担任主席。


MedSci高级学术顾问张博士就肿瘤介入领域常见问题,如何从临床设计和创新性角度挖掘高质量的临床研究,以及转化为高质量临床研究成果等角度介绍目前中国肿瘤介入领域的情况,以及如何通过规范的临床设计,发表高质量临床成果。MedSci资深编辑朱博士结合中国学者在临床研究过程中常见的问题,就科研成果SCI文章的结构性写作部分与广大师生交流、学习,并和在场的听众和嘉宾进行互动,得到热烈反响。

大会主席精彩点评:非常感谢拜耳公司多吉美团队,这是一个非常积极、努力、专业的团队,他们一直积极地为我们提供各种学术支持与培训机会。而这一次的SCI论文培训,在我看来是非常成功的,尽管以SCI为终点,但是起点非常高,张博士详细而专业地介绍了临床研究设计的各种规范与创新方法,而临床研究设计既是科研工作的第一步,也是科研工作的灵魂,好的临床研究设计才能有高质量的学术产出,我认为,这个讲座应该组织主任们来听,只有科室带头人重视了临床研究设计,并形成创新的意识与规范的准则,才能有高质量的科研产出。在此感谢MedSci两位博士的精彩演讲,并再次感谢拜耳公司!


MedSci将根据听者的反馈,继续组织并优化“临床科研中国行”全国巡回讲座的开展,为广大医务工作者的临床研究提供更多的信息和支持。


本次培训讲座由拜耳医药保健有限公司全力赞助,在此表示感谢!

讲座现场,听者与MedSci专家互动

MedSci高级学术顾问张博士正在演讲

MedSci资深编辑朱博士正在演讲

MedSci两位博士与大会主席交流

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2080686, encodeId=ac5320806864d, content=<a href='/topic/show?id=7f664e84367' target=_blank style='color:#2F92EE;'>#巡回讲座#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47843, encryptionId=7f664e84367, topicName=巡回讲座)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Dec 22 10:00:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279539, encodeId=42b112e953948, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404441, encodeId=5024140444145, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513896, encodeId=a0161513896bf, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2080686, encodeId=ac5320806864d, content=<a href='/topic/show?id=7f664e84367' target=_blank style='color:#2F92EE;'>#巡回讲座#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47843, encryptionId=7f664e84367, topicName=巡回讲座)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Dec 22 10:00:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279539, encodeId=42b112e953948, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404441, encodeId=5024140444145, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513896, encodeId=a0161513896bf, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2080686, encodeId=ac5320806864d, content=<a href='/topic/show?id=7f664e84367' target=_blank style='color:#2F92EE;'>#巡回讲座#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47843, encryptionId=7f664e84367, topicName=巡回讲座)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Dec 22 10:00:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279539, encodeId=42b112e953948, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404441, encodeId=5024140444145, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513896, encodeId=a0161513896bf, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2080686, encodeId=ac5320806864d, content=<a href='/topic/show?id=7f664e84367' target=_blank style='color:#2F92EE;'>#巡回讲座#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47843, encryptionId=7f664e84367, topicName=巡回讲座)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Sat Dec 22 10:00:00 CST 2012, time=2012-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279539, encodeId=42b112e953948, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1404441, encodeId=5024140444145, content=<a href='/topic/show?id=10aa1603137' target=_blank style='color:#2F92EE;'>#SCI论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16031, encryptionId=10aa1603137, topicName=SCI论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c572475119, createdName=般若傻瓜, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513896, encodeId=a0161513896bf, content=<a href='/topic/show?id=45ca34140ec' target=_blank style='color:#2F92EE;'>#医学期刊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34140, encryptionId=45ca34140ec, topicName=医学期刊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a210597497, createdName=1249884fm90暂无昵称, createdTime=Wed Jun 06 15:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=)]

相关资讯

SCI论文全攻略之审稿回复实例

附1:SCI扩展版和SCI核心版收录期刊的区别   SCI扩展版(以下简称SCIE)和SCI核心版(以下简称SCI)收录期刊还是有区别的,SCI期刊论文全部被SCI收录,SCIE期刊论文只是部分被SCI收录,这就是有的SCIE期刊一年有几百篇论文,却只有几十篇甚至十几篇论文被SCI收录的原因。具体到SCIE期刊上的一篇论文能否被SCI收录,还是要看美国ISI发布的报告,现在科技部信息研

SCI论文知识及写作投稿指南

本教程简单易明,信息量全,只要参考,很容易学会。 SCI论文知识及写作投稿指南.pdf

利用SCI撰写高水平论文 与投稿策略分析

本PPT由上海交通大学图书馆王琏嘉教授主讲 撰写SCI高水平论文与投稿策略分析.pdf

临床类文章的外文写作与投稿经验:个人详细总结

从去年8月份着手准备SCI文章,到今年1篇临床类文章成功接收,一篇小修,一篇大修,均已修回,虽然都是一些低影响因子的杂志(这跟个人水平及所学专业有关,泌尿外科number one杂志european urology也才8点多),但我对这样的结果已相当满足。通过阅读各位前辈的经验贴,我学到了许多东西,对我的选择杂志、投稿及修稿帮助都极大,在此表示感谢。刚开始酝酿idea的时候,我也是一头雾水,而且我

SCI论文投稿步骤实例讲解及其经验总结

1、 选择合适的SCI 期刊-Choose a journal。结合专业知识、2009 或2008 年度影响因子表和他人经验来综合选择要投递的期刊,他人的投稿经验,可以到MedSci网站:http://www.medsci.cn/sci/,查找相应的杂志,大多数杂志均有其他人的投稿经验,可供参考。尤其是注意审稿周期,以及投稿命中率两点,然后进入该期刊查询系统查询近年来的文章走向。2、 下载Intr

发SCI论文,难在哪里?

[SCI F]: SCI论文这点破事儿,在中国的“学术圈子”里是一个争议持续不断的老话题。在网上到处转载的文章《有些同行评议,不如SCI评价》,是我之前在科学网上发表的博文。 [SCI S]: 前不久,大侠的博文《眼界比SCI更重要》,又让这破事儿在科学网上折腾起波浪。真想对大侠说,在中国不是不爱眼界,是爱不起,那是战略上的事,是战略科学家们的管的事儿;俺们这些小伙子,还是爱SCI更切实际些。当